In 1964, Paul Terasaki and John McClelland (Nature 204:998, 1964) introduced the microlymphocytotoxicity test, known as complement dependent cytotoxicity assay or simply CDC, which became the standard serological assay for HLA typing and cross-matching in clinical tissue transplantation.
© 2004 - 2024 Immunopaedia.org.za
Sitemap - Privacy Policy - Cookie Policy - PAIA - Terms & Conditions
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.